Scientific Resources

Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.

Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.

End of Treatment Response Assessment After Frontline Therapy for Aggressive B-cell Lymphoma: Landmark Comparison of a Singular PET/CT scan vs Ultrasensitive Circulating Tumor DNA
December 12, 2023 | Presentation
Ultrasensitive ctDNA MRD Monitoring in early stage lung cancer with PhasED-Seq
April 20, 2023 | Poster
Ultrasensitive Detection of Circulating Tumor DNA In Untreated Diffuse Large B-cell Lymphoma
April 4, 2023 | Poster
Polatuzumab vedotin with dose-adjusted etoposide, cyclophosphamide, doxorubicin, and rituximab (Pola-DA-EPCH-R) for upfront treatment of aggressive B-cell non-Hodgkin lymphomas.
March 9, 2023 | Poster
Ultrasensitive MRD Profiling Predicts Outcomes in DLBCL after Frontline Therapy with Tafasitamab in Combination with Lenalidomide and R-CHOP
November 15, 2022 | Presentation
Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-cell Lymphoma
April 29, 2022 | Poster